Cystadane® (betaine anhydrous for oral solution) has long been a cornerstone in the treatment of homocystinuria, a rare genetic disorder characterized by elevated levels of homocysteine in the blood and urine. Approved by the U.S.…
Xolremdi(mavorixafor) is an innovative pharmaceutical compound that has gained significant attention in the medical and biotech industries. As a potential game-changer in targeted therapies, Xolremdi is being studied for its unique mechanism of action and…
Ojemda(tovorafenib) is an innovative precision medicine designed to combat specific types of cancer by targeting genetic mutations. As a next-generation kinase inhibitor, it represents a significant advancement in oncology, offering hope for patients with limited…
Anktiva(nogapendekin alfa inbakicept-pmln) is a cutting-edge therapeutic agent that has garnered significant attention in the medical and biotech communities. Understanding Anktiva’s mechanisms, applications, and benefits is crucial for healthcare professionals, researchers, and others exploring new…
Zevtera® (ceftobiprole medocaril sodium) is a fifth-generation cephalosporin antibiotic developed by Basilea Pharmaceutica. Approved by the U.S. FDA in April 2024, Zevtera offers a potent treatment option against a range of serious bacterial infections, including…
🫁 What Is Sotatercept-csrk? Winrevair™ (sotatercept-csrk) is a pioneering biologic therapy developed by Merck, approved by the FDA in March 2024 for the treatment of adults with pulmonary arterial hypertension (PAH), classified as World Health…
Caffeic Acid tablets, as a drug with the functions of hemostasis and leukocyte elevation, have demonstrated remarkable efficacy in clinical application in several departments in recent years. Wide Clinical Application According to Tencent News, Caffeic…
Tryvio (aprocitentan) is a novel antihypertensive medication developed by Idorsia Pharmaceuticals. Approved by the U.S. Food and Drug Administration (FDA) in March 2024, it offers a new therapeutic option for patients with resistant hypertension—those whose…
What Is Zelsuvmi Used For? ZELSUVMI™ (berdazimer) is a first-in-class topical medication that was approved by the U.S. Food and Drug Administration on January 5, 2024, making it the first new drug for the treatment…
In March 2024, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Rezdiffra (resmetirom), marking a significant milestone as the first approved treatment for nonalcoholic steatohepatitis (NASH), in adults with moderate to advanced…
Tevimbra, known generically as tislelizumab-jsgr, is a humanized IgG4 monoclonal antibody developed by BeiGene. It functions as a PD-1 inhibitor, aiming to enhance the body’s immune response against cancer cells. Approved for various indications, Tevimbra…
Letybo(letibotulinumtoxinA-wlbg), developed by South Korean biopharmaceutical company Hugel, has recently received FDA approval for the treatment of moderate to severe glabellar lines (frown lines) in adults. Known as Botulax in South Korea, Letybo has been…
